Login

Erik Kinnman, CEO, NeuroVive Pharmaceutical 00:00:00

Share On Facebook Share On Twitter

NeuroVive Pharmaceutical - Company presentation

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
CEO Jeff Guldner Discusses Clean Energy Transition and Leadership Amidst Crisis | Jeffrey B. Guldner, CEO , Pinnacle West Capital Corporation.
00:10:00
Investment Update: Navigating Market Discrepancies Amid Economic Challenges
00:10:00
invests in consumer technology with a particular interest in consumer software|Gautam Gupta,General Partner, TCV
00:10:00
Nick Samoulihan’s Approach to Achieving Targeted Income
00:10:00
Ankhor Gold's Investment and Development in Cambodia: An Overview
00:10:00
Understanding Financial Advisor Fees: A Guide from Richard Feight | Richard Feight, President, IAM Financial, LLC.
00:10:00
Common Pitfalls for Founder led Sales|
00:00:00
Innovation to Impact: Knee Outcomes for Medical Professionals-Daniel B. F. Saris, M.D., Ph.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
Chesser Resources: Advancing High-Grade Gold Discoveries in Senegal at One-to-One Mining Conference
00:10:00
Altius Minerals Corporation discusses strategy, innovation and the future of the mining industry|Brian F. Dalton, President & CEO of Altius Minerals
00:10:00
India's Manufacturing Renaissance: A Multi-Decade Opportunity | B.Gopkumar, CEO , Axis Mutual Fund.
00:10:00
Ed Harrison discusses the insights from Isentia's Leadership Index on the impact of presence following the Sydney launch event.|Edward John Harrison ceo of iSentia Group Ltd.

© 2026 Nehu